Systematic review of tirzepatide for adults living with obesity
study058
10.1136/bmjebm-2024-113253
BMJ Evidence-Based Medicine
systematic review
Systematic review of randomized trials of tirzepatide in adults with obesity.
The review found robust weight-loss efficacy with expected incretin-class adverse events.
tirzepatide
fat-loss|metabolism
advanced-metabolic-stack
semaglutide-vs-tirzepatide
published